These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 15934883)

  • 41. Refractory Chronic Immune-mediated Demyelinating Polyneuropathy.
    Shaibani A; Al Sultani H
    Neurol Clin; 2020 Aug; 38(3):591-605. PubMed ID: 32703471
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Predicting response to treatment in chronic inflammatory demyelinating polyradiculoneuropathy.
    Chan YC; Allen DC; Fialho D; Mills KR; Hughes RA
    J Neurol Neurosurg Psychiatry; 2006 Jan; 77(1):114-6. PubMed ID: 16361609
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The value of sensory electrophysiology in chronic inflammatory demyelinating polyneuropathy.
    Rajabally YA; Narasimhan M
    Clin Neurophysiol; 2007 Sep; 118(9):1999-2004. PubMed ID: 17644033
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Chronic polyradiculoneuritis and its frontiers].
    Vallat JM; Tabaraud F; Magy L; Macian F
    Rev Neurol (Paris); 2002 Dec; 158(12 Pt 2):S27-31. PubMed ID: 12690658
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Improving the management of chronic inflammatory demyelinating polyradiculoneuropathy.
    Allen JA; Bril V
    Neurodegener Dis Manag; 2016 Jun; 6(3):237-47. PubMed ID: 27230584
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Intravenous immunoglobulin for chronic inflammatory demyelinating polyradiculoneuropathy: the ICE trial.
    Hughes RA
    Expert Rev Neurother; 2009 Jun; 9(6):789-95. PubMed ID: 19496683
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Systematic reviews of treatment for chronic inflammatory demyelinating neuropathy.
    Hughes RA
    Rev Neurol (Paris); 2002 Dec; 158(12 Pt 2):S32-6. PubMed ID: 12690659
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Acquired inflammatory demyelinating neuropathies.
    Ensrud ER; Krivickas LS
    Phys Med Rehabil Clin N Am; 2001 May; 12(2):321-34, ix. PubMed ID: 11345010
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Are the treatments for chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) effective and safe? - A Cochrane Overview summary with commentary.
    Oaklander AL; Gimigliano F
    NeuroRehabilitation; 2019; 44(4):609-612. PubMed ID: 31256085
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Long-term neurophysiological and clinical response in patients with chronic inflammatory demyelinating polyradiculoneuropathy treated with subcutaneous immunoglobulin.
    Cirillo G; Todisco V; Tedeschi G
    Clin Neurophysiol; 2018 May; 129(5):967-973. PubMed ID: 29554579
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Update on therapy of chronic immune-mediated neuropathies.
    Briani C; Cocito D; Campagnolo M; Doneddu PE; Nobile-Orazio E
    Neurol Sci; 2022 Dec; 43(Suppl 2):605-614. PubMed ID: 33452933
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Chronic Inflammatory Demyelinating Polyneuropathy (CIDP): Current Therapies and Future Approaches.
    Svačina MKR; Lehmann HC
    Curr Pharm Des; 2022; 28(11):854-862. PubMed ID: 35339172
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Multifocal sensory demyelinating neuropathy: Report of a case.
    Oh SJ
    Muscle Nerve; 2017 Oct; 56(4):825-828. PubMed ID: 28000233
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Chronic inflammatory demyelinating polyneuropathy.
    Mathey EK; Pollard JD
    J Neurol Sci; 2013 Oct; 333(1-2):37-42. PubMed ID: 23146613
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Treatment's initiation in chronic inflammatory demyelinating polyradiculopathy (CIDP)].
    Uzenot D; Azulay JP; Pouget J
    Rev Neurol (Paris); 2007 Sep; 163 Spec No 1():3S68-76. PubMed ID: 18087233
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Anti-SGPG antibody in CIDP: nosological position of IgM anti-MAG/SGPG antibody-associated neuropathy.
    Tagawa Y; Yuki N; Hirata K
    Muscle Nerve; 2000 Jun; 23(6):895-9. PubMed ID: 10842265
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Rituximab in chronic immune mediated neuropathies: a systematic review.
    Chaganti S; Hannaford A; Vucic S
    Neuromuscul Disord; 2022 Aug; 32(8):621-627. PubMed ID: 35672205
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Subcutaneous immunoglobulin for maintenance treatment in chronic inflammatory demyelinating polyneuropathy (The PATH Study): study protocol for a randomized controlled trial.
    van Schaik IN; van Geloven N; Bril V; Hartung HP; Lewis RA; Sobue G; Lawo JP; Mielke O; Cornblath DR; Merkies IS;
    Trials; 2016 Jul; 17(1):345. PubMed ID: 27455854
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Electrophysiological sensory demyelination in typical chronic inflammatory demyelinating polyneuropathy.
    Rajabally YA; Samarasekera S
    Eur J Neurol; 2010 Jul; 17(7):939-44. PubMed ID: 20158514
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Chronic dysimmune neuropathies: Beyond chronic demyelinating polyradiculoneuropathy.
    Khadilkar SV; Deshmukh SS; Dhonde PD
    Ann Indian Acad Neurol; 2011 Apr; 14(2):81-92. PubMed ID: 21808468
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.